Nick Speakman

Nick Speakman is an accomplished finance professional with extensive experience in the pharmaceutical industry. Currently serving as Finance Director for Curium Pharma in the UK and Ireland since January 2023, Nick previously held the position of Finance and Commercial Director at M2i Limited, where significant contributions included leading the buyout of the M2i radiopharmaceutical business and steering the company to a successful disposal. As the Founder and Managing Director of Helvic Laboratories, Nick established the organization as the leading provider of pharmaceutical sterility testing in the UK before its sale to the Tentamus Group. Earlier roles included Finance Director at Erigal Limited and Senior Manager at Baker Tilly International, following a graduate Chartered Accountant training programme with KPMG, culminating in the role of Manager.